Ligand Pharm
(LGND)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1994 | 12-1993 | 12-1992 | 12-1991 | 12-1990 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -27,080 | -19,458 | -14,007 | -6,274 | -4,514 |
| Depreciation Amortization | 1,536 | 1,269 | 851 | 775 | 527 |
| Other Working Capital | 3,212 | -248 | -667 | 149 | 91 |
| Other Operating Activity | 8,022 | 7,827 | 3,331 | 42 | 0 |
| Operating Cash Flow | $-14,310 | $-10,609 | $-10,492 | $-5,308 | $-3,896 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -587 | -465 | -31 | N/A | 34 |
| Other Investing Activity | 1,650 | -43,083 | -5,038 | -978 | 1,810 |
| Investing Cash Flow | $1,063 | $-43,548 | $-5,069 | $-978 | $1,844 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 19,232 | 3,144 | 64,905 | 9,364 | -286 |
| Financing Cash Flow | $19,232 | $3,144 | $64,905 | $9,364 | $-286 |
| Beginning Cash Position | 1,642 | 52,654 | 3,311 | 231 | 2,568 |
| End Cash Position | 7,628 | 1,642 | 52,654 | 3,311 | 231 |
| Net Cash Flow | $5,986 | $-51,012 | $49,344 | $3,079 | $-2,337 |
| Free Cash Flow | |||||
| Operating Cash Flow | -14,310 | -10,609 | -10,492 | -5,308 | -3,896 |
| Free Cash Flow | -14,310 | -10,609 | -10,492 | -5,308 | -3,896 |